Avalyn completes enrollment in Phase 2b pulmonary fibrosis trial of AP01Aug 12Quarterly updateAvalyn Pharma Inc.pirfenidone solution
Pliant's BEACON-IPF trial terminated after DSMB recommendation; results postedAug 5Trial updatePliant Therapeutics, Inc.PLN-74809
MannKind reports Q2 2026 results with pediatric Afrezza and Furoscix ReadyFlow approvalsAug 5Quarterly updatefurosemide injection 80 mg/ 10 mlinsulin human
Glenmark's generic nintedanib esylate capsules (ANDA212555) listed as approved, with July 2021 approJul 9Regulatory decisionGlenmark Pharmaceuticalsnintedanib
MannKind registers Phase 2 trial of inhaled nintedanib for pulmonary fibrosisJul 1Trial updateMannkind Corporationnintedanib
Sign inSign in